ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive Non Small Cell Lung Cancer (NSCLC) Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00890825
Recruitment Status : Completed
First Posted : April 30, 2009
Last Update Posted : November 10, 2016
Sponsor:
Information provided by (Responsible Party):
AstraZeneca

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2011
  Actual Study Completion Date : November 2016
  Certification/Extension First Submitted : August 22, 2013

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 June 14, 2017 July 14, 2017
2 March 26, 2018  
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):